Reduced lymphatic reserve in heart failure with preserved ejection fraction

Tools

Rossitto, Giacomo and Mary, Sheon and McAllister, Christine and Neves, Karla Bianca and Haddow, Laura and Rocchiccioli, John Paul and Lang, Ninian Nicholas and Murphy, Clare Louise and Touyz, Rhian Merry and Petrie, Mark Colquhoun and Delles, Christian (2020) Reduced lymphatic reserve in heart failure with preserved ejection fraction. Journal of the American College of Cardiology, 76 (24). pp. 2817-2829. ISSN 1558-3597 (https://doi.org/10.1016/j.jacc.2020.10.022)

[thumbnail of Rossitto-JACC-2020-Reduced-lymphatic-reserve-in-heart-failure-with-preserved-ejection-fraction]
Preview
 Text. Filename: Rossitto_JACC_2020_Reduced_lymphatic_reserve_in_heart_failure_with_preserved_ejection_fraction.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo
Download (1MB)| Preview

Abstract

Background: Microvascular dysfunction plays an important role in the pathogenesis of heart failure with preserved ejection fraction (HFpEF). However, no mechanistic link between systemic microvasculature and congestion, a central feature of the syndrome, has yet been investigated. Objectives: This study aimed to investigate capillary–interstitium fluid exchange in HFpEF, including lymphatic drainage and the potential osmotic forces exerted by any hypertonic tissue Na+ excess. Methods: Patients with HFpEF and healthy control subjects of similar age and sex distributions (n = 16 per group) underwent: 1) a skin biopsy for vascular immunohistochemistry, gene expression, and chemical (water, Na+, and K+) analyses; and 2) venous occlusion plethysmography to assess peripheral microvascular filtration coefficient (measuring capillary fluid extravasation) and isovolumetric pressure (above which lymphatic drainage cannot compensate for fluid extravasation). Results: Skin biopsies in patients with HFpEF showed rarefaction of small blood and lymphatic vessels (p = 0.003 and p = 0.012, respectively); residual skin lymphatics showed a larger diameter (p = 0.007) and lower expression of lymphatic differentiation and function markers (LYVE-1 [lymphatic vessel endothelial hyaluronan receptor 1]: p < 0.05; PROX-1 [prospero homeobox protein 1]: p < 0.001) compared with control subjects. In patients with HFpEF, microvascular filtration coefficient was lower (calf: 3.30 [interquartile range (IQR): 2.33 to 3.88] l × 100 ml of tissue–1 × min–1 × mm Hg–1 vs. 4.66 [IQR: 3.70 to 6.15] μl × 100 ml of tissue–1 × min–1 × mm Hg–1; p < 0.01; forearm: 5.16 [IQR: 3.86 to 5.43] l × 100 ml of tissue–1 × min–1 × mm Hg–1 vs. 5.66 [IQR: 4.69 to 8.38] μl × 100 ml of tissue–1 × min–1 × mm Hg–1; p > 0.05), in keeping with blood vascular rarefaction and the lack of any observed hypertonic skin Na+ excess, but the lymphatic drainage was impaired (isovolumetric pressure in patients with HFpEF vs. control subjects: calf 16 ± 4 mm Hg vs. 22 ± 4 mm Hg; p < 0.005; forearm 17 ± 4 mm Hg vs. 25 ± 5 mm Hg; p < 0.001). Conclusions: Peripheral lymphatic vessels in patients with HFpEF exhibit structural and molecular alterations and cannot effectively compensate for fluid extravasation and interstitial accumulation by commensurate drainage. Reduced lymphatic reserve may represent a novel therapeutic target.

ORCID iDs

Rossitto, Giacomo, Mary, Sheon, McAllister, Christine, Neves, Karla Bianca ORCID logoORCID: https://orcid.org/0000-0001-5158-9263, Haddow, Laura, Rocchiccioli, John Paul, Lang, Ninian Nicholas, Murphy, Clare Louise, Touyz, Rhian Merry, Petrie, Mark Colquhoun and Delles, Christian;
CORE (COnnecting REpositories)